Table 2.
Anthropometric and Laboratory Measures at Baseline, Conclusion, and 3-Month Follow-Up Assessment, Pasos Adelante Program, Douglas, Arizona, 2004-2009
| Characteristic | Baseline, Mean (SD) (n = 305) | Conclusion, Mean (SD) (n = 255) | 3-Month Follow-Up, Mean (SD) (n = 221) |
|---|---|---|---|
| Anthropomorphic measure | |||
| Body mass index, kg/m2 | 31.4 (6.2) | 31.0 (6.1) | 30.9 (6.0) |
| Waist circumference, cm | 95.0 (14.6) | 91.2 (13.2) | 91.6 (13.0) |
| Hip circumference, cm | 110.7 (13.4) | 108.1 (12.1) | 107.9 (11.7) |
| Waist-to-hip ratio | 0.86 (0.09) | 0.84 (0.08) | 0.85 (0.08) |
| Systolic blood pressure, mm Hg | 125.0 (17.0) | 121.8 (15.4) | 124.9 (17.5) |
| Diastolic blood pressure, mm Hg | 76.9 (9.4) | 73.9 (8.6) | 75.2 (8.8) |
| Pulse, beats/30 seconds | 34.4 (4.9) | 33.9 (4.4) | 33.9 (4.4) |
| Laboratory measure | |||
| Total cholesterol, mg/dL | 191.6 (41.1) | 191.1 (38.2) | 193.0 (39.4) |
| HDL cholesterol, mg/dL | 44.6 (12.0) | 43.2 (12.1) | 45.6 (13.4) |
| LDL cholesterol, mg/dL | 122.2 (37.3) | 124.5 (34.1) | 123.1 (38.1) |
| Triglycerides, mg/dL | 144.8 (88.4) | 148.9 (172.5) | 148.7 (96.9) |
| Glucose, mg/dL | 103.0 (43.2) | 98.1 (28.4) | 99.3 (28.6) |
Abbreviations: SD, standard deviation; HDL, high-density lipoprotein; LDL, low-density lipoprotein.